enVista Envy hydrophobic acrylic intraocular lens (IOL)
Bausch + Lomb, Inc. · Decision date Sep 3, 2026
What did the FDA decide?
The FDA recorded decision OK30 on 2026-09-03 for PMA supplement P240005/S007, associated with the enVista Envy hydrophobic acrylic intraocular lens (IOL) from Bausch & Lomb, Inc. The supplement was filed as a 30-Day Notice under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The recorded statement covers the elimination of certain redundant post-coating incoming inspections for coated lens shuttles.
This action concerns manufacturing inspection steps for a lens component rather than a new approval of the whole IOL system. The device falls under product code MFK, category Lens, multifocal intraocular, specialty Ophthalmic. The source record includes no supporting documents, so the specific inspections removed, any replacement controls, and the basis for the OK30 decision remain unknown from this data alone.
FDA approval order statement
the elimination of certain redundant post-coating incoming inspections for coated lens shuttles
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ophthalmic
- Decision date
- Sep 3, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P240005/S007
- Regulatory pathway
- PMA supplement
- Applicant
- Bausch + Lomb, Inc.
- Product code
- MFK
- Decision code
- OK30
- Decision date
- Sep 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lens, multifocal intraocular.
- Applicant
- Bausch + Lomb, Inc.
- Product code
- MFK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P240005. Subsequent supplements may change the device or its indications.
FDA decision timeline
P240005 · Original PMA
enVista Envy hydrophobic acrylic intraocular lens (IOL), enVista Envy toric hydrophobic acrylic intraocular lens (IOL)
P240005/S007 received
Application receipt date recorded by FDA.
P240005/S007 · FDA decision
30-Day Notice
P240005/S008 · Related supplement
enVista Envy Hydrophobic Acrylic Intraocular Lens
P240005/S009 · Related supplement
enVista Envy Hydrophobic Acrylic Intraocular Lens
P240005/S010 · Related supplement
enVista Envy Hydrophobic Acrylic Intraocular Lens
Timeline entries are records held by MedtechLedger for P240005. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P240005
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Bausch + Lomb, Inc. | PMA approval | Oct 10, 2024 | FDA | |
| Bausch + Lomb, Inc. | PMA supplement | Sep 30, 2026 | FDA | |
| Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA | |
| Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA |
Explore the linked device profile
Other records with product code MFK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ClearView HD intraocular lens (IOL)P200020/S013 | Lenstec, Inc. | PMA supplement | Oct 23, 2026 | FDA |
TECNIS Multi-focal 3-pc, Model ZMA00P080010/S032 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA |
| Rayner Intraocular Lenses , Ltd. | PMA supplement | Sep 24, 2026 | FDA | |
| Lenstec, Inc. | PMA approval | Jul 22, 2022 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA approval | Jan 16, 2009 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bausch + Lomb, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1400 N. Goodman St., Rochester, NY, 14609
Sources and methodology
- Original FDA record: P240005/S007
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



